Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii

Cucé, 1980, Treatment of paracoccidioidomycosis, candidiasis lobomycosis and mycetoma with Ketoconazole, International Journal of Dermatology, 19, 405, 10.1111/j.1365-4362.1980.tb03740.x Dismukes, 1983, Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients, Annals of Internal Medicine, 98, 13, 10.7326/0003-4819-98-1-13 Drouhet, 1982, Ketoconazole: A new orally active antifungal agent in deep and superficial mycoses, Vol. 1, 59 Drouhet, 1983, Laboratory and clinical assessment of Ketoconazole in deep-seated mycoses, American Journal of Medicine, 74, 30, 10.1016/0002-9343(83)90512-0 Gordon, 1980, Immune response to aerobic pathogenic Actinomycetaceae, 526 Hay, 1983, Ketoconazole in the treatment of fungal infection: clinical and laboratory studies, American Journal of Medicine, 74, 16, 10.1016/0002-9343(83)90509-0 Heel, 1982, Practical clinical considerations, 147 Heiberg, 1981, Toxic hepatitis during Ketoconazole treatment, British Medical Journal, 283, 825, 10.1136/bmj.283.6295.825 Levine, 1982 Mahgoub, 1976, Medical Management of Mycetoma, Bulletin of the World Health Organization, 54, 303 Symoens, 1980, An evaluation of two years of clinical experience with Ketoconazole, Reviews of Infectious Diseases, 2, 674, 10.1093/clinids/2.4.674